Perinatal Asphyxia: Clinical Trials

4 trials for Perinatal Asphyxia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 not yet recruiting, 1 terminated. 4 Phase 2, 2 Phase 3, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 24Completed 2, Not yet recruiting 1, Terminated 1
Phase 32Completed 1, Not yet recruiting 1
Phase 11Completed 1

Follow Perinatal Asphyxia: new trials by email Literature Review of Perinatal Asphyxia trials Research Report on Perinatal Asphyxia

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Intranasal Stem Cells to Treat Perinatal Brain Injury to Combat Cerebral Palsy
MSC, marrow, Placebo - Perinatal Arterial Ischemic Stroke, Perinatal Asphyxia
Phase 2 / Phase 3Not yet recruitingUMC Utrecht1622027-04-012026-09-21
Neuroprotective Role of Erythropoietin in Perinatal Asphyxia
Erythropoietin - Perinatal Asphyxia
Phase 2 / Phase 3CompletedSheri Kashmir Institute of Medical Sciences1002012-06-012016-10-14
A Study of 2-Iminobiotin in Neonates With Perinatal Asphyxia
2-Iminobiotin - Perinatal Asphyxia
Phase 2TerminatedNeurophyxia B.V.62012-06-012017-05-25
Melatonin for Neuroprotection Following Perinatal Asphyxia
Melatonin - Perinatal Asphyxia
Phase 1 / Phase 2CompletedTanta University452012-01-012014-02-25

Narrower conditions

Asphyxia Neonatorum (1)  ·  Brain Diseases (1)  ·  Hypothermia (1)  ·  Hypoxia-Ischemia, Brain (1)

Broader conditions

Central Nervous System Diseases (2)  ·  Nervous System Diseases (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Signs and Symptoms (2)  ·  Body Temperature Changes (1)  ·  Brain Diseases (1)  ·  Brain Ischemia (1)  ·  Cardiovascular Diseases (1)  ·  Cerebrovascular Disorders (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Hypoxia (1)  ·  Hypoxia, Brain (1)  ·  Infant, Newborn, Diseases (1)  ·  Signs and Symptoms, Respiratory (1)  ·  Vascular Diseases (1)

Interventions

2-iminobiotin (1)  ·  Erythropoietin (1)  ·  Melatonin (1)

Sponsors

Neurophyxia B.V. (1)  ·  Sheri Kashmir Institute of Medical Sciences (1)  ·  Tanta University (1)  ·  UMC Utrecht (1)

Countries

Egypt (1)  ·  India (1)  ·  Turkey (Türkiye) (1)

Top investigators

Feroz Shaheen, MD (1)  ·  Heba Mahdy, MD (1)  ·  Paul Leufkens, PharmD (1)  ·  Prof. WAjid Ali (1)

NIH funding

2025 (1)